Autonomy, Desperation, and Consent In Experimental Medicine

Authors

  • Julie Gage Palmer Chicago, United States of America

DOI:

https://doi.org/10.18690/mls.19.1.43-72.2026

Keywords:

terminal illness, respect for persons, clinical trials, experimental drugs, surgical advances, retrospective medical studies

Abstract

The most salient bioethics principle in American medical care is respect for autonomous decision-making. This principle of autonomy is established in law through ‘informed consent’ rules, which have been refined in American law for more than a century. Desperately ill individuals who enroll in research trials often believe they are accessing new therapies that will benefit them personally, even when the consent forms they sign explicitly state that no benefit is promised. This ‘therapeutic misconception’ and related autonomy-based concerns cast doubt on the genuineness of informed consent obtained from desperately ill patients enrolling in research trials. Related concerns about comprehension and consent have shaped debates about whether terminally ill patients should have access to experimental medical products outside of research trials. Suggestions are offered for enhancing informed consent by desperately ill patients and for alternatives to steering them towards research trials.

Downloads

Download data is not yet available.

References

Downloads

Published

04.04.2026

Issue

Section

Articles

How to Cite

Gage Palmer, J. (2026). Autonomy, Desperation, and Consent In Experimental Medicine. Medicine, Law & Society, 19(1), 43–72. https://doi.org/10.18690/mls.19.1.43-72.2026